Hepatitis C is one of the viral infections that contain hepatitis C virus (HCV) that causes infection that primarily causes inflammation or damage leading to long-term liver dysfunction. It is usually transmitted by blood-to-blood contact, and includes sharing contaminated needles with infected blood products or the entry of infected blood into the body through other means. Hepatitis C is currently a global health concern as it places a significant burden on both public health systems and individuals. Acute hepatitis C may be mild and self-resolving, but long-term infection can lead to serious consequences, such as cirrhosis, liver cancer, and eventual liver failure in the absence of treatment. There are varying rates of progression among individuals, with some developing chronic hepatitis C and some shedding the virus within a few months. Chronic hepatitis C infection is usually asymptomatic, so it is difficult for a person to know he or she is infected until liver damage has progressed. For this reason, hepatitis C is also commonly referred to as a "silent" infection.
There are several genotypes of the hepatitis C virus, each with several subtypes. Genotype 1 is the most common type in the United States, but other genotypes are more prevalent in other areas of the world. Genotypic variations can affect disease progression and the virus's response to treatment, as some genotypes may be more resistant to specific antiviral treatments than others. The virus is an RNA virus, meaning it carries its genetic information in ribonucleic acid, as opposed to deoxyribonucleic acid in the case of DNA viruses. This enables HCV to change very quickly, making an effective response for the immune system impossible and making vaccines difficult to create. Antiviral agents have replaced vaccines in hepatocellular carcinomas because they have not yet been developed.
Hepatitis C is a bloodborne virus that is transmitted directly through blood. Direct blood contact can occur in several ways, but the most common is through sharing needles or injection materials among people who inject drugs. In addition, the risk of transmission may include health care settings where sterilization procedures are practiced unsafely, or in individuals who have received a blood transfusion or organ transplant from an infected person. Unfortunately, before blood screening was strictly implemented, many people unknowingly acquired the infection through a blood transfusion. This is now mostly rare due to improved screening protocols. Hepatitis C is not spread by casual contact such as hugging, kissing, or sharing food, and it is also not a sexually transmitted germ, although it can be transmitted through sexual contact, especially where blood is involved.
Both acute and chronic are self-explanatory stages that can be expected from a hepatitis C infection. To define acute hepatitis C, one can say, it is the first six months during which the virus infects the body and tries to fight it off. Without symptoms, the infection may go unnoticed in many people suffering from acute hepatitis C. In some cases, it happens that during the acute infection, the immune system manages to clear the virus; hence the host recovers completely. However, in many cases, the virus becomes chronic for several months or years before causing serious damage. If left untreated, years or even a lifetime may pass, leading to, eventually, liver-related complications, such as cirrhosis or liver cancer, which is primarily caused by chronic hepatitis C. Chronic hepatitis is determined when hepatitis C is present in the blood for more than six months. This type of infection is highly prevalent in people infected during adulthood. Most people infected with chronic hepatitis C have no symptoms in the early stages of infection, making it nearly impossible to detect without a blood test. However, liver damage may occur later, showing as infiltration that looks like lesions and reduced function, culminating in liver failure.
Hepatitis C causes unexplained damage to the liver organs, making them unable to perform functions such as detoxification, synthesizing proteins involved in blood clotting metabolism, and storing glycogen in people's bodies. One of the most worrying effects of chronic hepatitis is the development of cirrhosis, where the liver fails to function properly due to scarring of the organ. This disease can develop after years of inflammation caused by the hepatitis C virus and, eventually, can lead to liver failure when the liver is no longer able to perform essential functions. In addition, cirrhosis carries a serious risk of developing liver cancer (or hepatocellular carcinoma), which is one of the biggest killers of those who die from progressive liver disease caused by hepatitis C.
Not all individuals infected with hepatitis C will develop it as a long-term condition or suffer severe liver injury. Many factors, such as the person's age, virus genotype, co-existing health conditions such as HIV or alcohol abuse, and genetic factors affecting the immune response to the virus, all contribute to the progression of the infection. For example, young people have a higher risk of chronic hepatitis C and liver damage throughout their lives. On the other hand, some individuals can spontaneously rid their bodies of the virus without any treatment, especially those who develop an excellent immune response. Notably, most individuals with chronic hepatitis C will have no symptoms, but by then significant damage to their liver will have occurred. This makes regular monitoring and screening very important for early detection and subsequent prevention of complications.
Blood tests are performed to confirm a diagnosis of hepatitis C, which involves identifying any possible traces of that virus in the bloodstream. The first of these several tests is usually an antibody test, which looks for antibodies against the hepatitis C virus; if it tests positive, further testing is needed to assess whether there is an active infection and how much viral load (the amount of virus in the blood) there is. One may also perform a genotyping assay to help make treatment decisions for the individual as this usually follows those tests. In addition to blood tests, imaging tests using modalities such as liver biopsy or ultrasound may also be involved to assess how much damage the chronic infection has caused to the liver.
There have been advances in the treatment of hepatitis C in recent years. Previously, hepatitis C treatment options were very limited and usually meant treating the individual with interferon-based therapies, which caused significant side effects. Thanks to direct-acting antiviral agents (DAAs), the treatment of hepatitis C has become radically different. DAAs specifically block certain stages of the viral lifecycle, so they allow the immune system to clear the infection by preventing the virus from replicating. In terms of cure rates, DAAs are very impressive, with success rates above 90 percent in many patients, and they are usually prescribed as oral tablets for several weeks to months, depending on the regimen. Finally, DAAs are well accepted and tolerated because they have fewer side effects than older treatments, and they are revolutionizing the treatment of hepatitis C.
Treatment of hepatitis C aims to eliminate the virus from the body and prevent liver damage. In addition to antiviral therapy, lifestyle modifications, such as abstaining from alcohol, may be necessary to manage other health conditions, including obesity, diabetes, and heart disease, which further complicate liver damage. Patients with advanced liver disease may require some other interventions, such as managing the complications of cirrhosis with medication, or even liver transplantation in the event of liver failure.
Hepatitis C is a preventable disease, and although no vaccination is available, its transmission can still be reduced. The most effective means of preventing hepatitis C is to avoid contact with contaminated blood. This also includes not sharing needles or any other drug-taking items, ensuring blood products are screened for the virus, and following proper infection control procedures in health care settings. Regular testing for the virus is recommended for people who are at the highest risk for hepatitis C, such as injection drug users and those with multiple sexual partners, as such practices increase the likelihood of transmission. Early detection and treatment are essential to reduce serious liver complications, including cirrhosis and liver cancer.
Infection from hepatitis C takes the form of a viral attack that is primarily directed to the liver within the human internal body. If the infection is not taken care of by treatment, there are chances that chronic liver disease, cirrhosis and liver cancer may occur. The mode of transmission is through blood, 'blood contact', while considering that casual contact does not transmit the disease in any way. There are different potential effects among individuals suffering from this disease, ranging from a few days without obvious symptoms, which means that it would be futile to detect it without considering a well-defined method. One of the ambitions of the control campaign revolves around prevention through safe practices, early detection and proper management of cases. Advances in the field of antivirals have given a new meaning to prognosis; in fact, it has opened new doors to the process of treating many infected individuals.
